Article

AAO LIVE: Study compares increased incidence of new strabismus after tube shunt surgery in pediatric, adult patients

Author(s):

During a presentation at the American Academy of Ophthalmology’s 2022 annual meeting at McCormick Place in Chicago, Maria A. Guzman Aparicio, MD, and Teresa C. Chen, MD, detailed their research that found that pediatric patients have a significantly higher incidence of new-onset strabismus after tube shunt surgery for glaucoma compared with adults.

The American Academy of Ophthalmology's 2022 annual meeting is being held at McCormick Place in Chicago. (Images courtesy of McCormick Place)

The American Academy of Ophthalmology's 2022 annual meeting is being held at McCormick Place in Chicago. (Images courtesy of McCormick Place)

During a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Maria A. Guzman Aparicio, MD, and Teresa C. Chen, MD, from Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, detailed their research that found that pediatric patients have a significantly higher incidence of new-onset strabismus after tube shunt surgery for glaucoma compared with adults. 

According to past literature, adults who undergo Ahmed (New World Medical) and Baerveldt (Abbott Medical Optics) tube shunt surgeries have postoperative strabismus 2% to 12.7% of the time after 1 to 5 years. In children, the percentages range from 3% to 4.2% with Ahmed valve surgery after 16 to 24 months of follow-up.

Maria A. Guzman Aparicio, MD

Maria A. Guzman Aparicio, MD

In their current study with longer follow-up periods, Guzman Aparicio and Chen sought to compare the frequency of strabismus after tube shunt surgery in the adult versus pediatric populations and to identify risk factors for strabismus after tube shunt surgery.

The study included patients treated between September 1998 and September 2021. One surgeon performed all surgeries at 1 center. Pediatric patients were defined as those under 18 years of age and adults as those 18 years and older. 

Patients were excluded if they had less than 6 months of follow-up or if they had concomitant major ocular surgery.

A total of 202 patients (223 eyes) were included, of whom 169 were adults (183 eyes) and 33 were children (40 eyes). The adults were a mean age of 63.6 years, and the children were 5.2 years. A total of 237 procedures were performed, 45 in children and 192 in adults. Average follow-up was 6.1 ± 4.8 years (range, 0.6 months to 20.1 years).

Among the 237 procedures, 4% of eyes underwent 2 or 3 tube shunt procedures. Ten percent of the eyes in the pediatric population, and 2.7% of the adult population were in this group. 

Incidence of new-onset strabismus after tube shunt surgery

The determination of new-onset strabismus among a combined total of 172 adults and children without preexisting strabismus indicated that 13% of pediatric patients had new-onset strabismus after a tube shunt procedure. This is in contrast to 0% of adults with new-onset strabismus after tube shunt surgery (at 6 months or at last follow-up).

The primary take-home messages from this analysis were as follows:

- New-onset strabismus developed in 13% of pediatric patients vs. 0% of adult patients.

- In pediatric and adult patients who had pre-existing strabismus, 100% continued to have strabismus after tube shunt surgery.

Risk factors for strabismus after tube shunt surgery were being a pediatric patient, being a pediatric patient with more than 1 tube placed, and having pre-existing strabismus.

“Before doing tube shunt surgery in children, it is important to educate parents of the possibility of new-onset postoperative strabismus in up to 13% of patients,” Guzman Aparicio said.

“Best surgical technique and implant choice may minimize the chance of postoperative strabismus,” Chen concluded. “We hypothesize that our low rates of postoperative strabismus in adults may be due to putting glaucoma implants over instead of under the muscles and using Baerveldt 250 models over the 350 model.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.